ArticleEJNMMI reports2025
Fatal mycosis fungoides, misdiagnosed as contact dermatitis.
Article in EJNMMI reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMycosis fungoides (MF) is a rare subtype of non-Hodgkin's lymphoma that primarily involves the skin. Its slow progression over several years and diverse clinical presentations-including itchy patches, plaques, or tumors-often lead to initial diagnosis of inflammatory dermatoses such as eczema or psoriasis, making accurate diagnosis challenging. CASE PRESENTATION: We present Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG PET/CT) findings of a 61-year-old man with histologically confirmed cutaneous T-cell lymphoma (CTCL), mycosis fungoides (MF). The disease initially manifested as an itching rash on his palms, which gradually progressed over a year to involve his trunk and extremities, ultimately affecting 70% of his body surface area despite multiple treatments, including prednisone, dupilumab, methotrexate, and adalimumab. The patient was initially misdiagnosed and treated for contact dermatitis for three years. After the final diagnosis of MF, his condition continued to deteriorate despite IV antibiotics, palliative radiation, and one cycle of brentuximab vedotin. The patient succumbed to the disease 23 days after the MF diagnosis.
conclusionThis report highlights the clinical overlap between inflammatory dermatoses and mycosis fungoides and serves as a reminder to clinicians to consider MF in patients with persistent, atypical dermatitis and to employ comprehensive diagnostic tools to guide management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.